source:[1] New Cancer Therapy Offers Hope For 'Incurable' Leukaemia in Early Trial - ScienceAlert (https://www.sciencealert.com/new-cancer-thera ...)[2] Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium - BioSpace (https://www.biospace.com/press-releases/astel ...)[3] IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal Melanoma - BioSpace (https://www.biospace.com/press-releases/ideay ...)